Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Microtubule and mitosis dynamics, and Cancer, Hypoxia, and Metabolism.
NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents
Therapeutic Potential of Afatinib in<i>NRG1</i>Fusion-Driven Solid Tumors: A Case Series
Afatinib as a novel potential treatment option for <i>NRG1</i> fusion-positive tumors.
NRG1-fusion positive gastrointestinal tumours: afatinib as a novel potential treatment option
Targeting NRG1-fusions in multiple tumour types: Afatinib as a novel potential treatment option
NRG1-fusion-driven solid tumours: A case series indicating the therapeutic potential of afatinib
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
Non-reproducible sequence artifacts in FFPE tissue: an experience report
A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
Activation of IL-6R/JAK1/STAT3 Signaling Induces <i>De Novo</i> Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation